Ebru Tekin Turhan

Rencell is a targeted therapy against metastatic renal cell cancer, which significantly prolongs disease-free survival. However, Rencell's international wholesale price of $1,000 for one month of treatment makes the drug unaffordable for many patients in China.

Published 24 Jun 2013

Reference 5806

Topic Marketing

Industry Pharmaceuticals

Region Asia

View case